We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Médecins Sans Frontières insisted that prices should come further down from the revised price of the drug, bedaquiline, hailed as the backbone of DR-TB treatment by WHO.